Sustained colonic delivery of nutritional compounds could be one of the most promising approaches to prevent obesity and associated metabolic diseases by, e.g., sustained GLP‐1 release. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.